Due to its possible cytotoxic effects, osimertinib, a medication widely used in the treatment of NSCLC (NSCLC), has become a subject of considerable interest.The phrase 'osimertinib cytotoxic' encapsulates the primary concern regarding the drug's ability to induce cytotoxicity in cancer cells.This article delves into the cytotoxic potential of osimertinib, exploring its processes, advantages, difficulties, and the current research in this field.Osimertinib, a third generation EGFR TKI (TKI), exerts its cytotoxic effects by targeting the EGFR (EGFR) in cancer cells.This section discusses the molecular pathways by which osimertinib induces cytotoxicity, including…
